SALLY MARKELL: Open Payments
NPI 1851720783 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 13 payments from 5 companies in 2025. Trend: 2023 $133 · 2024 $81 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $81 |
| Novo Nordisk Inc | 3 | $69 |
| Lilly USA, LLC | 3 | $66 |
| Amgen Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
Products named: ELIQUIS, Wegovy, MOUNJARO, ZEPBOUND, REPATHA, Ozempic, VOQUEZNA.
Industry payments across DC — which companies pay providers there.
